Australia Viscosupplementation Market Size & Outlook
Related Markets
Australia viscosupplementation market highlights
- The Australia viscosupplementation market generated a revenue of USD 58.6 million in 2024 and is expected to reach USD 117.3 million by 2033.
- The Australia market is expected to grow at a CAGR of 7.5% from 2025 to 2033.
- In terms of segment, single injection was the largest revenue generating product in 2024.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2024 | USD 58.6 million |
| Market revenue in 2033 | USD 117.3 million |
| Growth rate | 7.5% (CAGR from 2025 to 2033) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, Australia accounted for 1.1% of the global viscosupplementation market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, Japan viscosupplementation market is projected to lead the regional market in terms of revenue in 2033.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 117.3 million by 2033.
Single injection was the largest segment with a revenue share of 48.29% in 2024. Horizon Databook has segmented the Australia viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2021 to 2033.
Osteoarthritis predominant condition and is the most common form of arthritis in Australia that leads to knee and hips replacement surgery. According to the Australian Bureau of Statistics (ABS), 2014–15 National Health Survey (NHS) about 2.1 million i.e., 9% of the total population in Australia have been reported suffering from this condition.
Osteoarthritis represented over half (59%) of all arthritic conditions in 2014 – 2015. Around 21% i.e., 1 out of 5 Australians, aged over 45 suffers from osteoarthritis. Among the population, aged 80 years and older the condition is more common, with around 35% of people in this age group reporting the condition. Osteoarthritis is also more common in females than males, affecting 10% of females compared to 6% of males.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Lifecore Biomedical Inc | View profile | 459 | 3515 Lyman Boulevard, Chaska, MN, United States, 55318 | https://www.lifecore.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Anika Therapeutics Inc | View profile | 357 | 32 Wiggins Avenue, Bedford, MA, United States, 01730 | https://www.anika.com |
| LG Chem | View profile | 10001+ | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | https://www.lgchem.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| DePuy Synthes | View profile | 5001-10000 | Raynham, Massachusetts, United States, North America | https://depuysynthes.com |
| Zimmer Biomet Holdings Inc | View profile | 18000 | 345 East Main Street, Warsaw, IN, United States, 46580 | https://www.zimmerbiomet.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
Australia viscosupplementation market size, by product, 2021-2033 (US$M)
Australia Viscosupplementation Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
